Insider · CIK 0001756240

Noblett Karen

Reports to the SEC for 1 company · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001756240

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-31	Axonics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+27.5K sh	—	—	45,716
2024-01-31	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−11.3K sh	$67.74	−$765K	34,428
2024-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,500 sh	—	—	0
2024-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−15K sh	—	—	0
2024-01-08	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−16K sh	$69.00	−$1.1M	18,216
2023-12-28	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−7,051 sh	$63.28	−$446K	34,215
2023-12-26	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−949 sh	$63.00	−$59.8K	41,266
2023-02-01	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−136 sh	$60.43	−$8,219.119	43,010
2023-02-01	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−795 sh	$61.02	−$48.5K	42,215
2023-01-31	Axonics, Inc.A Award	Chief Medical Officer	AAward	+5,000 sh	—	—	36,599
2023-01-31	Axonics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10.3K sh	—	—	46,849
2023-01-31	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−2,167 sh	$61.17	−$133K	44,682
2023-01-31	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−1,536 sh	$61.12	−$93.9K	43,146
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+15K sh	—	—	15,000
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+5,000 sh	—	—	5,000
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,250 sh	—	—	0
2023-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,000 sh	—	—	0
2022-09-12	Axonics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+18.5K sh	$14.19	+$263K	50,118
2022-09-12	Axonics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+14K sh	$25.82	+$361K	64,082
2022-09-12	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−32.5K sh	$78.16	−$2.54M	31,599
2022-09-12	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−18.5K sh	—	—	2,963
2022-09-12	Axonics, Inc.Stock Options (Right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−14K sh	—	—	6,348
2022-09-07	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−10.5K sh	$71.53	−$748K	31,599
2022-03-18	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−13.5K sh	$57.23	−$774K	42,053
2022-02-03	Axonics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+19.5K sh	—	—	62,266
2022-02-03	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−6,343 sh	$48.21	−$306K	55,923
2022-02-03	Axonics, Inc.S Sale	Chief Medical Officer	SSale	−339 sh	$49.03	−$16.6K	55,584
2022-02-03	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−5,333 sh	—	—	0
2022-02-03	Axonics, Inc.Performance-Based Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−14.1K sh	—	—	0
2022-01-31	Axonics, Inc.A Award	Chief Medical Officer	AAward	+5,350 sh	—	—	42,803
2022-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+4,250 sh	—	—	4,250
2022-01-31	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+3,250 sh	—	—	3,250
2019-07-23	Axonics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,402 sh	$0.98	+$8,233.96	48,122
2019-07-23	Axonics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,002 sh	$1.63	+$9,783.26	54,124
2019-07-23	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,002 sh	—	—	11,998
2019-07-23	Axonics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−8,402 sh	—	—	1,198
2019-01-30	Axonics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+35.6K sh	—	—	35,555
2019-01-30	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+2,667 sh	—	—	2,667
2019-01-30	Axonics, Inc.Performance-Based Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+2,667 sh	—	—	2,667

Recent filings

Accepted (ET)
Feb 24
Noblett Karen0001562180-24-001013
SEC(opens sec.gov)
Jan 104
Noblett Karen0001562180-24-000425
SEC(opens sec.gov)
Dec 284
Noblett Karen0001562180-23-008578
SEC(opens sec.gov)
Feb 24
Noblett Karen0001562180-23-000872
SEC(opens sec.gov)
Sep 204
Noblett Karen0001562180-22-006777
SEC(opens sec.gov)

Companies

Axonics, Inc.Chief Medical Officer

Address

26 TECHNOLOGY DRIVE

IRVINE, CA, 92618